pentobarbital decreases levels of panobinostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Powerful CYP3A4 inducers can cut down panobinostat ranges by ~70% and cause therapy failure. pentobarbital will lower the extent or effect of bazedoxifene/conjugated estroge